Expression of Enzymes Involved in Estrogen Metabolism in Human Prostate
Author(s) -
Yasukazu Takase,
MarieHélène Lévesque,
Van LuuThe,
Mohamed Elalfy,
Fernand Labrie,
Georges Pelletier
Publication year - 2006
Publication title -
journal of histochemistry and cytochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.971
H-Index - 124
eISSN - 1551-5044
pISSN - 0022-1554
DOI - 10.1369/jhc.6a6927.2006
Subject(s) - stromal cell , in situ hybridization , prostate , lncap , aromatase , estrogen , prostate cancer , endocrinology , biology , medicine , hyperplasia , immunohistochemistry , dehydroepiandrosterone , cancer research , androgen , gene expression , cancer , hormone , breast cancer , biochemistry , gene
There is evidence that estrogens can directly modulate human prostate cell activity. It has also been shown that cultured human prostate cancer LNCaPcan synthesize the active estrogen estradiol (E2). To elucidate the metabolism of estrogens in the human prostate, we have studied the expression of enzymes involved in the formation and inactivation of estrogens at the cellular level. 17β-Hydroxysteroid dehydrogenase (17β-HSD) types 1, 2, 4, 7, and 12, as well as aromatase mRNA and protein expressions, were studied in benign prostatic hyperplasia (BPH) specimens using in situ hybridization and immunohistochemistry. For 17β-HSD type 4, only in situ hybridization studies were performed. Identical results were obtained with in situ hybridization and immunohistochemistry. All the enzymes studied were shown to be expressed in both epithelial and stromal cells, with the exception of 17β-HSD types 4 and 7, which were detected only in the epithelial cells. On the basis of our previous results, showing that 3β-HSD and 17β-HSD type 5 are expressed in human prostate, and of the present data, it can be concluded that the human prostate expresses all the enzymes involved in the conversion of circulating dehydroepiandrosterone (DHEA) to E2. The local biosynthesis of E2 might be involved in the development and/or progression of prostate pathology such as BPH and prostate cancer through modulation of estrogen receptors, which are also expressed in epithelial and stromal cells. (J Histochem Cytochem 54:911-921, 2006)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom